Two Sigma Advisers
CARM

Two Sigma Advisers’s Carisma Therapeutics CARM Stock Holding History

Two Sigma Advisers’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,130
Closed -$13.8K – 2600
2022
Q4 		$13.8K Buy
+1,130
New +$11.9K ﹤0.01% 2447
2022
Q1 		– Sell
-17,659
Closed -$288K – 2750
2021
Q4 		$288K Sell
17,659
-95,847
-84% -$1.93M ﹤0.01% 2153
2021
Q3 		$1.8M Sell
113,506
-24,810
-18% -$1.19M ﹤0.01% 1314
2021
Q2 		$12.8M Sell
138,316
-10,645
-7% -$679K 0.03% 476
2021
Q1 		$7.75M Buy
148,961
+113,010
+314% +$5.33M 0.02% 673
2020
Q4 		$971K Buy
35,951
+28,930
+412% +$734K ﹤0.01% 1579
2020
Q3 		$197K Buy
7,021
+4,705
+203% +$94.1K ﹤0.01% 2159
2020
Q2 		$33K Buy
2,316
+525
+29% +$7.08K ﹤0.01% 2440
2020
Q1 		$20K Buy
1,791
+439
+32% +$7.19K ﹤0.01% 2413
2019
Q4 		$28K Buy
+1,352
New +$31.1K ﹤0.01% 2316
2019
Q2 		– Sell
-527
Closed -$11K – 2321
2019
Q1 		$11K Hold
527
– – ﹤0.01% 2266
2018
Q4 		$15K Sell
527
-890
-63% -$28.4K ﹤0.01% 2318
2018
Q3 		$61K Sell
1,417
-985
-41% -$38.4K ﹤0.01% 2170
2018
Q2 		$94K Buy
+2,402
New +$106K ﹤0.01% 2279
2015
Q3 		– Sell
-1,731
Closed -$98K – 1821
2015
Q2 		$98K Buy
+1,731
New +$244K ﹤0.01% 1809

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers's CARM Position: Q1 2023 in Review

Two Sigma Advisers sold out of Carisma Therapeutics (CARM) in Q1 2023, closing a stake of 1,130 shares — an estimated $13.8K sold.

Two Sigma Advisers first reported a position in CARM in Q2 2015 and held it in 15 quarters. The position peaked at $12.8M in Q2 2021. 37 funds tracked by Wall St. Rank hold CARM as of Q1 2023.

  • Two Sigma Advisers reported no remaining Carisma Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 1,130 Carisma Therapeutics shares in Q1 2023, an estimated $13.8K.
  • Two Sigma Advisers first reported a position in Carisma Therapeutics in Q2 2015 and held it in 15 quarters.
  • Two Sigma Advisers's Carisma Therapeutics position peaked at $12.8M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.